PE86199A1 - Sulfonamida inhibidor de la enzima farnesilo transferasa - Google Patents

Sulfonamida inhibidor de la enzima farnesilo transferasa

Info

Publication number
PE86199A1
PE86199A1 PE1998000508A PE00050898A PE86199A1 PE 86199 A1 PE86199 A1 PE 86199A1 PE 1998000508 A PE1998000508 A PE 1998000508A PE 00050898 A PE00050898 A PE 00050898A PE 86199 A1 PE86199 A1 PE 86199A1
Authority
PE
Peru
Prior art keywords
cells
transferasa
aryl
alkyl
farnesilo
Prior art date
Application number
PE1998000508A
Other languages
English (en)
Inventor
Ronald J Doll
Viyyoor M Girijavallabhan
F George Njoroge
Arthur G Taveras
Bancha Vibulbhan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE86199A1 publication Critical patent/PE86199A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA (I) O SU SAL, DONDE A ES N o N-OXIDO; CUANDO X ES N o CH SOLO HAY UN ENLACE CON C11 o CUANDO X ES CARBONO Y SE UNE CON UN DOBLE ENLACE AL C11; X1 Y X2 SON BROMO, CLORO, YODO; SOLO UNO DE X3 Y X4 ES H Y EL RESTO SON BROMO, YODO, FLUOR; R5, R6, R7 Y R8 SON H, ALQUILO, ARILO o -CONR20R21; R20 Y R21 SON H, ALQUILO, ALCOXI, ARILO, ENTRE OTROS o R5 Y R6 o R7 Y R8 SON =O O =S; R ES ALQUILO, ARILO, ARILALQUILO, -NR10R11, ENTRE OTROS; R10 Y R11 SON H, ALQUENILO, ALQUILO, ENTRE OTROS. EL COMPUESTO (I) INHIBE A LA ENZIMA FARNESIL RAS TRANSFERASA PUDIENDO SER UTIL PARA INHIBIR EL DESARROLLO ANORMAL DE CELULAS TUMORALES QUE EXPRESAN UN ONCOGEN RAS ACTIVADO, LAS CELULAS INHIBIDAS SON CELULAS DE TUMORES PANCREATICOS, CELULAS DE CANCER DE PULMON, CELULAS TUMORALES DE LEUCEMIA MIELOIDE, CELULAS DE TUMORES FOLICULARES TIROIDEOS
PE1998000508A 1997-06-17 1998-06-15 Sulfonamida inhibidor de la enzima farnesilo transferasa PE86199A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87705097A 1997-06-17 1997-06-17

Publications (1)

Publication Number Publication Date
PE86199A1 true PE86199A1 (es) 1999-09-24

Family

ID=25369146

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000508A PE86199A1 (es) 1997-06-17 1998-06-15 Sulfonamida inhibidor de la enzima farnesilo transferasa

Country Status (14)

Country Link
EP (1) EP0989980A1 (es)
JP (1) JP2002507192A (es)
KR (1) KR20010013826A (es)
CN (1) CN1267290A (es)
AR (1) AR012989A1 (es)
AU (1) AU8253698A (es)
CA (1) CA2293358C (es)
CO (1) CO4940475A1 (es)
HU (1) HUP0004627A2 (es)
IL (1) IL133393A0 (es)
NZ (1) NZ501619A (es)
PE (1) PE86199A1 (es)
WO (1) WO1998057949A1 (es)
ZA (1) ZA985218B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6689789B2 (en) 1997-06-17 2004-02-10 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US7517884B2 (en) 1998-03-30 2009-04-14 Kalypsys Inc. Sulfonyl-substituted bicyclic compounds as modulators of PPAR
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
CA2429720C (en) * 2000-11-29 2009-12-29 Schering Corporation Tricyclic compounds useful for the inhibition of farnesyl protein transferase
WO2006055187A1 (en) 2004-10-29 2006-05-26 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as modulators of ppar
KR101464767B1 (ko) 2005-10-25 2014-11-24 칼립시스, 인코포레이티드 Ｐｐａｒ의 조절자의 염 및 대사질환을 치료하는 방법
US20080176861A1 (en) 2007-01-23 2008-07-24 Kalypsys, Inc. Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis
BR112015019818A2 (pt) * 2013-02-19 2017-07-18 Icahn School Med Mount Sinai composto, uso de um composto, e, composição farmacêutica

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76057A (en) * 1993-10-15 1997-06-30 Schering Corp Tricyclic sulfonamide compounds, pharmaceutical compositions containing them, which are useful for inhibition of g-protein function and for treatment of proliferative diseases and process for producing them
IL117797A0 (en) * 1995-04-07 1996-08-04 Pharmacopeia Inc Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
CA2293358C (en) 2008-08-05
ZA985218B (en) 1998-12-15
AR012989A1 (es) 2000-11-22
CN1267290A (zh) 2000-09-20
AU8253698A (en) 1999-01-04
HUP0004627A2 (hu) 2001-10-28
NZ501619A (en) 2002-02-01
CO4940475A1 (es) 2000-07-24
IL133393A0 (en) 2001-04-30
JP2002507192A (ja) 2002-03-05
KR20010013826A (ko) 2001-02-26
WO1998057949A1 (en) 1998-12-23
CA2293358A1 (en) 1998-12-23
EP0989980A1 (en) 2000-04-05

Similar Documents

Publication Publication Date Title
PE82799A1 (es) Compuestos de urea n-sustituida inhibidores de farnesilo transferasa
PE86199A1 (es) Sulfonamida inhibidor de la enzima farnesilo transferasa
MX9401195A (es) Oligomeros de esteres tapados en los extremos poli-etoxi/propoxisulfonados adecuados como agentes liberadores de sucio en composicionesdetergentes.
ES2188779T3 (es) Complejos activadores con eficacia catalitica para compuestos peroxi.
ATE390962T1 (de) Chemische oxidierung von flüchtigen organischen verbindungen
ES8106757A1 (es) Procedimiento para la fabricacion de compuestos germicidas abase de yodo,de alta estabilidad
CY1106223T1 (el) Μεθοδοι διαμορφωσης λειτουργιας σepινης/θρεονινης πρωτεϊνης κινασης με βασισμενες σε 5-αζακινοξαλινη ενωσεις
ATE73164T1 (de) Chemilumineszente zusammensetzung.
ATE30170T1 (de) Bleich- und reinigungsmittelzusammensetzungen.
IE33021L (en) Guanylhydrazones
DE3477675D1 (en) Detergent compositions
ATE210178T1 (de) Bleichsystem
ATE95812T1 (de) Sulfon-peroxycarbonsaeuren.
AR009635A1 (es) Proceso de oxidacion enzimatica.
CY1110438T1 (el) Χιμαιρικες (πρωτεϊνες συντηξης) gfp-ακουορινης ως βιοφωταυγεις αναφορεις ca++ στο επιπεδο του ενος κυτταρου
TR200101312T2 (tr) Ağartıcı terkipleri.
MY124198A (en) Electrolyte rebalancing system
ES2189121T3 (es) Mezcla de estabilizantes para materiales organicos.
ATE255280T1 (de) Elektrolyt-ausgleichssystem
ATE47590T1 (de) P-sulphophenylalkylcarbonate und deren verwendung als bleichmittelaktivatoren.
DK313186D0 (da) P-sulfofenylkarbonater samt detergentblandinger og detergentadditiverindeholdende saadanne forbindelser
DE60306523D1 (de) Verwendung von übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen liganden als bleichkatalysatoren und bleichmittelzusammensetzung
MXPA94005411A (es) Compuestos novedosos de piperidina para utilizarsecomo estabilizantes para materiales organicos.
ATE18134T1 (de) Verwendung von n-halogenphenyl-benzisothiazolen.
DE69734378D1 (de) An der Regenierung von Luciferin beteiligtes Enzym

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed